ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
5.32 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.533 | 0 | 0 | 0 | 1.538 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.272 | 0.261 | 0.263 | 0.257 | 0.259 | 0.253 | 0.247 | 0.221 | 0.247 | 0.251 | 0.229 | 0.217 | 0.222 | 0.229 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0.533 | 0 | -0.272 | -0.261 | 1.275 | -0.257 | -0.259 | -0.253 | -0.247 | -0.221 | -0.247 | -0.251 | -0.229 | -0.217 | -0.222 | -0.229 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 1 | 0 | 0 | 0 | 0.829 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 24.64 | 31.97 | 31.202 | 28.94 | 21.96 | 24.481 | 22.388 | 18.787 | 19.516 | 16.295 | 14.723 | 13.834 | 16.828 | 16.745 | 12.899 | 15.517 | 11.697 | 12.113 | 8.831 | 7.723 | 7.254 | 6.96 | 5.632 | 5.04 | 5.212 |
| General & Administrative Expenses
| 8.078 | 7.6 | 7.116 | 7.077 | 7.03 | 6.947 | 6.294 | 6.205 | 6.162 | 5.824 | 5.971 | 6.862 | 6.43 | 6.06 | 5.557 | 5.54 | 4.856 | 4.297 | 3.8 | 3.4 | 1.925 | 1.811 | 1.465 | 1.315 | 1.134 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | -0.261 | -0.263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.843 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.078 | 7.6 | 7.116 | 7.077 | 6.769 | 6.684 | 6.294 | 6.205 | 6.162 | 5.824 | 5.971 | 6.862 | 6.43 | 6.06 | 5.557 | 5.54 | 4.856 | 4.297 | 3.8 | 3.4 | 1.925 | 1.811 | 1.465 | 1.315 | 1.134 |
| Other Expenses
| 0 | 0 | 0 | 0 | 3.979 | 3.098 | 3.204 | 2.048 | 1.733 | 5 | 5 | 0.409 | 0 | -11.697 | 0 | 0.015 | 0 | -0.007 | 0.044 | 0.074 | 0.066 | 0.074 | 0.072 | 0.073 | 0.07 |
| Operating Expenses
| 32.718 | 39.57 | 38.318 | 36.017 | 28.729 | 31.165 | 28.682 | 24.992 | 25.678 | 22.119 | 20.694 | 20.696 | 23.258 | 22.805 | 18.456 | 21.057 | 16.553 | 16.41 | 12.631 | 11.123 | 9.179 | 8.771 | 7.097 | 6.355 | 6.346 |
| Operating Income
| -32.718 | -39.57 | -38.318 | -36.017 | -28.99 | -31.428 | -28.682 | -24.992 | -25.678 | -22.119 | -25.694 | -20.696 | -23.258 | -22.805 | -18.456 | -21.057 | -16.553 | -28.282 | -25.602 | -11.123 | -9.179 | -8.771 | -7.097 | -6.355 | -6.346 |
| Operating Income Ratio
| 0 | -74.24 | 0 | 0 | 0 | -20.434 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.697 | 3.263 | 3.752 | 4.054 | 3.979 | 3.098 | 3.204 | 2.048 | 1.733 | 1.272 | 0.865 | 0.409 | 0.099 | 0.034 | 0.03 | 0.048 | 0.044 | 0.023 | 0.054 | 0.099 | 0.307 | 0.417 | 0.548 | 0.39 | 0.331 |
| Income Before Tax
| -30.021 | -36.307 | -34.566 | -31.963 | -25.011 | -28.33 | -25.478 | -22.944 | -23.945 | -20.847 | -24.829 | -20.287 | -23.159 | -22.771 | -18.426 | -21.009 | -16.509 | -28.259 | -25.548 | -11.024 | -8.872 | -8.354 | -6.549 | -5.965 | -6.015 |
| Income Before Tax Ratio
| 0 | -68.118 | 0 | 0 | 0 | -18.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0.218 | 2.243 | -0.257 | 0.137 | -1.986 | -1.272 | -0.865 | 0 | -0.099 | -0.034 | -0.03 | -0.033 | -0.088 | -0.03 | -0.01 | -0.025 | -0.548 | -0.417 | -0.548 | -0.39 | -0.592 |
| Net Income
| -30.021 | -36.307 | -34.566 | -31.963 | -25.011 | -28.33 | -25.478 | -22.944 | -21.959 | -19.575 | -23.964 | -20.287 | -23.06 | -22.771 | -18.426 | -21.009 | -16.509 | -28.259 | -25.548 | -11.024 | -8.872 | -8.354 | -6.549 | -5.965 | -6.015 |
| Net Income Ratio
| 0 | -68.118 | 0 | 0 | 0 | -18.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.42 | -0.51 | -0.49 | -0.45 | -0.37 | -0.49 | -0.44 | -0.5 | -0.49 | -0.49 | -0.61 | -0.51 | -0.58 | -0.58 | -0.47 | -0.57 | -0.45 | -0.84 | -0.84 | -0.51 | -0.32 | -0.44 | -0.34 | -0.31 | -0.31 |
| EPS Diluted
| -0.42 | -0.51 | -0.49 | -0.45 | -0.37 | -0.49 | -0.44 | -0.5 | -0.49 | -0.49 | -0.61 | -0.51 | -0.58 | -0.58 | -0.47 | -0.57 | -0.45 | -0.84 | -0.84 | -0.51 | -0.32 | -0.44 | -0.34 | -0.31 | -0.31 |
| EBITDA
| -32.718 | -39.266 | -38.048 | -35.745 | -28.729 | -31.165 | -28.425 | -24.733 | -25.425 | -21.872 | -20.473 | -20.449 | -23.007 | -22.576 | -18.239 | -20.835 | -16.324 | -16.176 | -12.391 | -10.877 | -8.929 | -8.501 | -6.827 | -6.109 | -6.104 |
| EBITDA Ratio
| 0 | -73.67 | 0 | 0 | 0 | -20.263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |